Product Information

TOPIRAMATE 50 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0401 per EA under NDC 69097012303. Its NADAC has been published 617 times since Jan 28, 2015.

FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE 50 MG TABLET

Topiramate
$0.0401per EA

Strength

50 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097012303

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076343

FDA Approved

3/27/2009

TE Code

AB

On Market Since

6/12/2014

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 50 MG TABLET has been published 617 times since Jan 28, 2015, and over the history we have for it it has declined 47.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0401 per EA
All-time high$0.0767 (Feb 11, 2015)
All-time low$0.0319 (Nov 20, 2024)
52-week high$0.0401
52-week low$0.0336
Median price$0.0473
Average price$0.0477
Largest weekly change+31.7% (Aug 21, 2024)
Weeks tracked617
Tracking sinceJan 28, 2015

Price History

1W

+1.0%

1M

+8.3%

3M

+14.6%

6M

+14.8%

1Y

+2.8%

3Y

-1.7%

5Y

-18.6%

All

-47.6%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 50 MG TABLET, manufactured by Cipla USA Inc., is $0.0401 per EA (NDC 69097012303), effective Nov 18, 2026.

How has the price of TOPIRAMATE 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 50 MG TABLET has declined 47.6%. It has been tracked across 617 weekly CMS publications since Jan 28, 2015.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 50 MG TABLET?

Since Jan 28, 2015, the NADAC for TOPIRAMATE 50 MG TABLET has ranged from a low of $0.0319 (Nov 20, 2024) to a high of $0.0767 (Feb 11, 2015), with a median of $0.0473 per EA.

Are there cheaper alternatives to TOPIRAMATE 50 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 50 MG TABLET, is $0.0373 per EA — about 7% below TOPIRAMATE 50 MG TABLET.

Who manufactures TOPIRAMATE 50 MG TABLET?

TOPIRAMATE 50 MG TABLET (NDC 69097012303) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.